Carmat SA (EPA:ALCAR)
France · Delayed Price · Currency is EUR 0.0990
0.00 (0.00%)
Sep 24, 2025, 5:35 PM CET
Carmat Revenue
In the year 2024, Carmat had annual revenue of 7.34M EUR with 91.40% growth. Carmat had revenue of 3.70M in the half year ending December 31, 2024, with 952.99% growth.
Revenue
7.34M
Revenue Growth
+91.40%
P/S Ratio
0.84
Revenue / Employee
48.00K
Employees
153
Market Cap
6.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.34M | 3.51M | 91.40% |
| Dec 31, 2023 | 3.84M | 3.36M | 704.40% |
| Dec 31, 2022 | 477.00K | -1.76M | -78.68% |
| Dec 31, 2021 | 2.24M | 2.23M | 24,755.56% |
| Dec 31, 2020 | 9.00K | -5.00K | -35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Bluelinea Société Anonyme | 11.68M |
| Implanet | 11.10M |
| Mauna Kea Technologies | 8.18M |
| Affluent Medical | 5.27M |